Clinical Trial Update: CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for CC-97540 in antineutrophil cytoplasmic antibody-associated vasculitis, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Drugs mentioned

• CC-97540

Snippet

Sponsor: Marcela V. Maus, M.D.,Ph.D. | Conditions: Antineutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING